Royal Bank Of Canada Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock

Key Points

• Royal Bank of Canada raised its target on Cigna to $337 with an "outperform" rating, implying roughly 19% upside
• Cigna beat Q1 estimates—$7.79 EPS vs. $7.60 expected and $68.5B revenue—and raised FY‑2026 adjusted EPS guidance to $30.35, signaling stronger operating performance.
• Management said it will exit the ACA individual exchange business in 2027 (impacting ~369,000 members) and is pursuing strategic alternatives for its eviCore unit, steps that reduce revenue exposure and add near‑term execution risk.

Cigna Group (NYSE:CI - Get Free Report) had its target price raised by analysts at Royal Bank Of Canada from $333.00 to $337.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has an "outperform" rating on the health services provider's stock. Royal Bank Of Canada's price objective points to a potential upside of 18.98% from the company's previous close.

Several other research analysts have also issued reports on CI. Zacks Research raised Cigna Group from a "strong sell" rating to a "hold" rating in a research report on Monday, January 5th. Piper Sandler dropped their target price on shares of Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, March 3rd. Wall Street Zen raised shares of Cigna Group from a "hold" rating to a "buy" rating in a research report on Saturday, February 7th. Truist Financial upped their price target on Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a report on Tuesday, February 17th. Finally, TD Cowen raised their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a "buy" rating in a research note on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $336.20.

Cigna Group Stock Down 2.5%

Shares of NYSE CI traded down $7.35 during mid-day trading on Friday, reaching $283.23. 678,894 shares of the company's stock were exchanged, compared to its average volume of 1,685,059. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $274.34 and a 200 day simple moving average of $276.94. The firm has a market capitalization of $74.64 billion, a price-to-earnings ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.26. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group's revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts expect that Cigna Group will post 30.32 EPS for the current fiscal year.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the business's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company's stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company's stock.

Institutional Trading of Cigna Group

A number of hedge funds have recently modified their holdings of CI. Cary Street Partners Investment Advisory LLC increased its stake in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider's stock valued at $100,000 after purchasing an additional 36 shares in the last quarter. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider's stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. IHT Wealth Management LLC grew its holdings in Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider's stock worth $423,000 after acquiring an additional 38 shares during the last quarter. Whetstone Capital Advisors LLC lifted its position in Cigna Group by 4.9% during the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider's stock valued at $228,000 after acquiring an additional 39 shares during the period. Finally, Leavell Investment Management Inc. increased its stake in Cigna Group by 3.8% during the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider's stock valued at $318,000 after purchasing an additional 40 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q1 results beat expectations — Cigna reported $7.79 EPS and revenue of about $68.5B, topping estimates and showing year‑over‑year revenue growth; the print supports the firm's profitability outlook. Cigna posts Q1 beat as Evernorth powers topline growth
• Positive Sentiment: Company raised FY‑2026 adjusted EPS guidance to at least $30.35 (vs. consensus ~30.32), a modest lift that signals confidence in operating performance. The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook
• Positive Sentiment: Evernorth (health services/PBM) drove topline strength — Evernorth revenue grew meaningfully and helped offset pharmacy cost pressures, underpinning the beat. Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
• Neutral Sentiment: Wells Fargo nudged its price target to $305 but kept an "equal weight" rating — a modest endorsement that implies limited near‑term upside from that shop. Benzinga
• Negative Sentiment: Cigna announced it will exit the ACA/Obamacare individual exchange business in 2027, affecting roughly 369,000 members — the withdrawal reduces revenue exposure but raises concerns about lost premium volume, regulatory scrutiny and transition costs. Cigna is becoming the second major insurer to exit from the ACA market
• Negative Sentiment: Management is pursuing strategic alternatives for its eviCore unit and exiting parts of the business, actions that create near‑term execution risk and investor uncertainty despite potential long‑term benefits. Cigna to exit ACA market, pursue strategic alternatives for eviCore unit

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.